Compare VVPR & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VVPR | YI |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United Kingdom | China |
| Employees | N/A | N/A |
| Industry | Power Generation | Retail-Drug Stores and Proprietary Stores |
| Sector | Utilities | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.2M | 38.1M |
| IPO Year | 2016 | N/A |
| Metric | VVPR | YI |
|---|---|---|
| Price | $2.96 | $3.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 312.4K | 12.0K |
| Earning Date | 01-01-0001 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $61,000.00 | ★ $1,979,883,442.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 281.25 | N/A |
| 52 Week Low | $0.62 | $3.19 |
| 52 Week High | $8.88 | $11.35 |
| Indicator | VVPR | YI |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 40.29 |
| Support Level | $2.37 | $3.32 |
| Resistance Level | $2.78 | $3.94 |
| Average True Range (ATR) | 0.22 | 0.23 |
| MACD | 0.10 | 0.03 |
| Stochastic Oscillator | 64.21 | 50.00 |
Vivopower International PLC is a sustainable energy solutions B Corporation specializing in electric solutions for customized and ruggedized fleet applications, battery and microgrids, solar, and critical power technology and services. The company's core purpose is to provide turnkey decarbonization solutions that help customers progress toward net-zero carbon status. VivoPower operates across five reportable segments: Electric Vehicles, Sustainable Energy Solutions, Solar Development, Digital Assets, and Corporate Office, with personnel and operations in Australia, the Netherlands, the United Kingdom, the United States, and the Philippines.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.